Filtered By:
Drug: Cymbalta
This page shows you your search results in order of date.
Order by Relevance | Date
Total 139 results found since Jan 2013.
Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis
The optimal dose of duloxetine in the management of fibromyalgia remains still controversial. Therefore, a systematic review and meta-analysis to investigate efficacy and safety of duloxetine was conducted. Th...
Source: Journal of Orthopaedic Surgery and Research - July 17, 2023 Category: Orthopaedics Authors: Filippo Migliorini, Nicola Maffulli, J örg Eschweiler, Alice Baroncini, Andreas Bell and Giorgia Colarossi Tags: Systematic Review Source Type: research
A Patient with a History of Fibromyalgia Reports for an Intraoral Incisional Biopsy
A patient with a past medical history significant for fibromyalgia presents for an incisional oral biopsy. The condition is being managed pharmacologically with duloxetine and ibuprofen. Given the patient ’s medical condition and medications, specific considerations were placed on chair positioning, muscle pain and tenderness, and achieving hemostasis through local measures. The patient was advised to follow up in 2 weeks for postoperative evaluation.
Source: Dental Clinics of North America - July 11, 2023 Category: Dentistry Authors: Roopali Kulkarni, Sunday Akintoye Source Type: research
Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study
CONCLUSIONS: This is the first randomised controlled study demonstrating the effectiveness of the adding on therapy of PEA+ALC to DLX+PGB in FM patients.PMID:37378482 | DOI:10.55563/clinexprheumatol/pmdzcq
Source: Clinical and Experimental Rheumatology - June 28, 2023 Category: Rheumatology Authors: Fausto Salaffi Sonia Farah Piercarlo Sarzi-Puttini Marco Di Carlo Source Type: research
Predicting acupuncture efficacy in fibromyalgia: results of a pragmatic open-label study
CONCLUSIONS: High TPC and a tendency for pain magnification predict immediate treatment failure, while duloxetine therapy predicts it three months after completion of the acupuncture course. The identification of clinical characteristics of unfavourable response to acupuncture could help to implement a cost-effective prevention of treatment failure in FM.PMID:37223911 | DOI:10.55563/clinexprheumatol/1xr38b
Source: Clinical and Experimental Rheumatology - May 24, 2023 Category: Rheumatology Authors: Marco Di Carlo Giacomo Beci Edoardo Cipolletta Fausto Salaffi Source Type: research
Antidepressants for pain management in adults with chronic pain: a network meta-analysis
CONCLUSIONS: Our review and NMAs show that despite studies investigating 25 different antidepressants, the only antidepressant we are certain about for the treatment of chronic pain is duloxetine. Duloxetine was moderately efficacious across all outcomes at standard dose. There is also promising evidence for milnacipran, although further high-quality research is needed to be confident in these conclusions. Evidence for all other antidepressants was low certainty. As RCTs excluded people with low mood, we were unable to establish the effects of antidepressants for people with chronic pain and depression. There is currently ...
Source: Cochrane Database of Systematic Reviews - May 9, 2023 Category: General Medicine Authors: Hollie Birkinshaw Claire M Friedrich Peter Cole Christopher Eccleston Marc Serfaty Gavin Stewart Simon White R Andrew Moore David Phillippo Tamar Pincus Source Type: research
51-Year-Old Woman With Fever, Cough, and Myalgias
A 51-year-old woman presented to the emergency department (ED) during the summertime with a 2-day history of fever up to 39.2 °C, nonproductive cough, myalgias, and nausea without associated diarrhea or vomiting. Her medical comorbidities included nicotine dependence with a 20-pack-year smoking history, common variable immune deficiency, quiescent multiple sclerosis not receiving immunomodulatory therapy, heart failure wi th preserved ejection fraction, hypertension, and fibromyalgia. Medications at the time of presentation were nortriptyline, cyclobenzaprine, aspirin, and duloxetine.
Source: Mayo Clinic Proceedings - March 1, 2023 Category: Internal Medicine Authors: Jack McHugh, Ryan Khodadadi, Priya Sampathkumar Tags: Residents ’ clinic Source Type: research
Fibromyalgia: Diagnosis and Management
Am Fam Physician. 2023 Feb;107(2):137-144.ABSTRACTFibromyalgia is a chronic, centralized pain syndrome characterized by disordered processing of painful stimuli. Fibromyalgia is diagnosed more frequently in women and occurs globally, affecting 2% of people in the United States. Patients with fibromyalgia have diffuse chronic pain, poor sleep, fatigue, cognitive dysfunction, and mood disturbances. Comorbid conditions, such as functional somatic syndromes, psychiatric diagnoses, and rheumatologic conditions may be present. The Fibromyalgia Rapid Screening Tool is a helpful screening method for patients with diffuse chronic p...
Source: Pain Physician - February 15, 2023 Category: Anesthesiology Authors: Bradford T Winslow Carmen Vandal Laurel Dang Source Type: research
